National Center for Global Health, Istituto Superiore di Sanità, 00161 Rome, Italy.
Department of Biomedicine and Prevention, University of Rome Tor Vergata, 00133 Rome, Italy.
Nutrients. 2023 Jul 24;15(14):3282. doi: 10.3390/nu15143282.
Breastfed Malawian infants from Human Immunodeficiency Virus (HIV)-uninfected and HIV-infected women who received antiretroviral therapy were followed until 12 months of age, allowing us to evaluate plasma levels of ferritin, vitamin A (as retinol-binding protein, RBP), and vitamin D (25(OH)D) at six months, as well as nutritional status and growth between six and 12 months. Ferritin and RBP levels were adjusted for inflammation. The study included 88 infants, 63 of whom were part of a recent cohort (2019-2021) that included 49 HIV-exposed but uninfected (HEU) and 14 HIV-unexposed and uninfected (HUU) infants, as well as 25 infants (all HEU) from an earlier cohort (2008-2011). No differences were observed between HEU and HUU infants regarding micronutrient levels, anthropometric indexes, growth, and rates of stunting, being underweight, or wasting. HEU infants from the earlier cohort, when compared to more recent HEU infants, had significantly worse anthropometric measures at six months and inferior growth between six and twelve months. Overall, ferritin deficiency involved 68.6% of infants, while vitamin A and vitamin D deficiency involved 8% and 1.2% of infants, respectively. Micronutrient deficiencies were not associated with HIV exposure, cohort, stunting, being underweight, or wasting. At six months, stunting, being underweight, and wasting involved 25.0%, 2.7% and 2.8% of infants, respectively, with no differences related to HIV exposure. Ferritin deficiency at six months was associated with inferior subsequent growth. In this small observational study conducted in Malawian infants, no major nutritional gap was observed between HIV-exposed and HIV-unexposed infants, though the study highlighted specific nutritional deficiencies that deserve attention. High rates of stunting and ferritin deficiency were observed in the first year of life in Malawian infants, irrespective of maternal HIV status; a significant association between ferritin deficiency and worse subsequent growth was found. Vitamin A and vitamin D deficiencies were much less frequent. Based on the data observed, nutritional interventions should give priority to the correction of ferritin deficiency and chronic undernutrition.
马拉维接受抗逆转录病毒疗法的 HIV 未感染和 HIV 感染的母乳喂养婴儿,在 12 个月龄时进行随访,使我们能够在 6 个月时评估铁蛋白、维生素 A(视黄醇结合蛋白,RBP)和维生素 D(25(OH)D)的血浆水平,以及 6 至 12 个月之间的营养状况和生长情况。铁蛋白和 RBP 水平根据炎症进行了调整。该研究纳入了 88 名婴儿,其中 63 名婴儿来自最近的队列(2019-2021 年),包括 49 名 HIV 暴露但未感染(HEU)和 14 名 HIV 未暴露且未感染(HUU)婴儿,以及来自较早队列(2008-2011 年)的 25 名婴儿(均为 HEU)。HEU 婴儿和 HUU 婴儿在微量营养素水平、人体测量指标、生长以及发育迟缓、体重不足或消瘦的发生率方面没有差异。与最近的 HEU 婴儿相比,较早队列的 HEU 婴儿在 6 个月时的人体测量指标明显较差,6 至 12 个月之间的生长情况也较差。总体而言,68.6%的婴儿存在铁蛋白缺乏,8%和 1.2%的婴儿分别存在维生素 A 和维生素 D 缺乏。微量营养素缺乏与 HIV 暴露、队列、发育迟缓、体重不足或消瘦无关。6 个月时,分别有 25.0%、2.7%和 2.8%的婴儿出现发育迟缓、体重不足和消瘦,与 HIV 暴露无关。6 个月时的铁蛋白缺乏与随后的生长不良相关。在这项在马拉维婴儿中进行的小型观察性研究中,HIV 暴露和未暴露的婴儿之间没有发现明显的营养差距,但研究强调了值得关注的具体营养缺乏问题。在马拉维婴儿的生命第一年,观察到高比例的发育迟缓率和铁蛋白缺乏,无论母亲的 HIV 状况如何;发现铁蛋白缺乏与随后的生长不良之间存在显著关联。维生素 A 和维生素 D 缺乏的情况要少得多。根据观察到的数据,营养干预应优先纠正铁蛋白缺乏和慢性营养不良。